The DOI matches its Crossref record; 128 of the 128 references it cites were found in a registry or an index.
Sarcopenic Obesity: Epidemiologic Evidence, Pathophysiology, and Therapeutic Perspectives
Abstract
Purpose of review This review provides a comprehensive update on the definition, assessment, epidemiology, pathophysiology, clinical implications, and therapeutic approach of sarcopenic obesity (SO) and highlights the challenges, limitations, and knowledge gaps in SO research. Recent findings The confluence of a rapidly aging population with rising obesity rates has led to the phenotype of SO, defined as the concurrent presence of sarcopenia and obesity. Despite efforts, a standardized definition of SO is still lacking. Its prevalence varies widely between studies, depending on population characteristics and different definitions. The major pathogenetic mechanisms include age-related changes in body composition and hormonal milieu, positive energy balance, pro-inflammatory pathways, and insulin resistance. Lifestyle interventions, including caloric restriction and physical activity, are the cornerstones of SO treatment. SO is a multifaceted syndrome with serious clinical implications. The development and implementation of effective prevention and treatment strategies is a top priority based on its dramatically increasing health impact.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“2) negative clinical interactions between obesity and sarcopenia, leading to a synergistically higher risk for metabolic disease and functional impairment compared to those caused by the cumulative risk from each separate condition [78,79].”
From Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO consensus statement (2022) · cites this paper as [79]
In the citing paper
“1) bidirectional, pathogenic interaction between body FM accumulation and loss of skeletal muscle mass and function;”
From Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO consensus statement (2022) · cites this paper as [79]
In the citing paper
“SO associates with a high risk of hospitalization, loss of independence, disability, frailty, increased risk of fractures, impaired quality of life, higher mortality, and multimorbidity [8–12].”
From The critical role of oxidative stress in sarcopenic obesity (2021) · cites this paper as [12]
In the citing paper
“As such, it is difficult to reach a consensus due to the multiple methods of evaluation for each condition, the use of some imprecise techniques (such as body mass index (BMI)), and the existence of different cut-off points for some values according to the population to be evaluated [12]”
From The critical role of oxidative stress in sarcopenic obesity (2021) · cites this paper as [12]
In the citing paper
“Although the impact of sarcopenia has been well-demonstrated, the effect of obesity on it emerges as a new public health problem (2).”
From Diabetes and Sarcopenic Obesity: Pathogenesis, Diagnosis, and Treatments (2020) · cites this paper as [2]
Citations
Cites
Frailty in Older Adults: Evidence for a Phenotype
Fried, L. P., Tangen, C. M., Walston, J., Newman, A. B., Hirsch, C., Gottdiener, J., Seeman, T., Tracy, R., Kop, W. J., Burke, G., et al. (2001) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/56.3.m146 · Cited by 24,907
Sarcopenia: revised European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., Cooper, C., Landi, F., Rolland, Y., Sayer, A. A., et al. (2019) · Age and Ageing · doi:10.1093/ageing/afy169 · Cited by 13,818
(2000) · PubMed · Cited by 13,173
Sarcopenia: European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Baeyens, J. P., Bauer, J. M., Boirie, Y., Cederholm, T., Landi, F., Martin, F. C., Michel, J.-P., Rolland, Y., Schneider, S. M., et al. (2010) · Age and Ageing · doi:10.1093/ageing/afq034 · Cited by 11,601
Guralnik, J. M., Simonsick, E. M., Ferrucci, L., Glynn, R. J., Berkman, L. F., Blazer, D. G., Scherr, P. A., & Wallace, R. B. (1994) · Journal of Gerontology · doi:10.1093/geronj/49.2.m85 · Cited by 9,792
Garber, C. E., Blissmer, B., Deschenes, M. R., Franklin, B. A., Lamonte, M. J., Lee, I.-M., Nieman, D. C., & Swain, D. P. (2011) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e318213fefb · Cited by 9,319
The metabolic phenotype in obesity: Fat mass, body fat distribution, and adipose tissue function
Goossens, G. H. (2017) · Obesity Facts · doi:10.1159/000471488 · Cited by 8,481
Sarcopenia in Asia: Consensus Report of the Asian Working Group for Sarcopenia
Chen, L.-K., Liu, L.-K., Woo, J., Assantachai, P., Auyeung, T.-W., Bahyah, K. S., Chou, M.-Y., Chen, L.-Y., Hsu, P.-S., Krairit, O., et al. (2014) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2013.11.025 · Cited by 4,051
Sarcopenia: revised European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., Cooper, C., Landi, F., Rolland, Y., Sayer, A. A., et al. (2019) · Age and Ageing · doi:10.1093/ageing/afz046 · Cited by 3,803
Fielding, R. A., Vellas, B., Evans, W. J., Bhasin, S., Morley, J. E., Newman, A. B., Abellan van Kan, G., Andrieu, S., Bauer, J., Breuille, D., et al. (2011) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2011.01.003 · Cited by 3,256
Cited by
Definition and Diagnostic Criteria for Sarcopenic Obesity: ESPEN and EASO Consensus Statement
Donini, L. M., Busetto, L., Bischoff, S. C., Cederholm, T., Ballesteros-Pomar, M. D., Batsis, J. A., Bauer, J. M., Boirie, Y., Cruz-Jentoft, A. J., Dicker, D., et al. (2022) · Obesity Facts · doi:10.1159/000521241 · Cited by 1,019
Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO consensus statement
Donini, L. M., Busetto, L., Bischoff, S. C., Cederholm, T., Ballesteros-Pomar, M. D., Batsis, J. A., Bauer, J. M., Boirie, Y., Cruz-Jentoft, A. J., Dicker, D., et al. (2022) · Clinical Nutrition · doi:10.1016/j.clnu.2021.11.014 · Cited by 566
“…and loss of skeletal muscle mass and function; (2) negative clinical interactions between obesity and sarcopenia, leading to a synergistically higher risk for metabolic disease and functional impairment compared to those caused by the cumulative risk from each separate condition [78, 79].”
Chen, L.-K., Hsiao, F.-Y., Akishita, M., Assantachai, P., Lee, W.-J., Lim, W. S., Muangpaisan, W., Kim, M., Merchant, R. A., Peng, L.-N., et al. (2025) · Nature Aging · doi:10.1038/s43587-025-01004-y · Cited by 262
“However, analogous to the ‘obesity paradox’ in older adults, the operational definition of sarcopenic obesity and its clinical implications need further exploration 90,93,94 .”
Diabetes and Sarcopenic Obesity: Pathogenesis, Diagnosis, and Treatments
Wang, M., Tan, Y., Shi, Y., Wang, X., Liao, Z., & Wei, P. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00568 · Cited by 231
Obesity Paradox: Fact or Fiction?
Simati, S., Kokkinos, A., Dalamaga, M., & Argyrakopoulou, G. (2023) · Current Obesity Reports · doi:10.1007/s13679-023-00497-1 · Cited by 169
Self-citation
Metadata
- Authors
- Koliaki, C., Liatis, S., Dalamaga, M., & Kokkinos, A.
- Affiliations
- National and Kapodistrian University of Athens (GR)
- Corresponding author
- Kokkinos, Alexander
- Venue
- Current Obesity Reports
- Published
- 2019-10-25
- Volume
- 8
- Issue
- 4
- Pages
- 458-471
- ISSN
- 2162-4968 (ISSN-L)
- OpenAlex
- W2982275681
- Semantic Scholar
- 1efc92261c75835e243df98691e8d7f1ea224cf3
- Cited by
- 176
- References
- 127
- Citations by year
- 2026: 15 · 2025: 32 · 2024: 39 · 2023: 28 · 2022: 34 · 2021: 17 · 2020: 11
- FWCI
- 1.83
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Current Obesity Reports (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Health Sciences › Medicine › Physiology (medical) › Body Composition Measurement Techniques
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Keywords
- sarcopenic obesity, sarcopenia, obesity, aging, body composition, insulin resistance, inflammation, energy balance, caloric restriction, physical activity, prevalence, pathophysiology, treatment, prevention
- MeSH terms
- Aged, Aging, Animals, Body Composition, Humans, Insulin Resistance, Life Style, Obesity, Exercise, Prevalence, Sarcopenia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Sarcopenic Obesity: Epidemiologic Evidence, Pathophysiology, and Therapeutic Perspectives. https://app.cochat.ai/papers/10.1007/s13679-019-00359-9
- The paper
- Koliaki, C., Liatis, S., Dalamaga, M., & Kokkinos, A. (2019). Sarcopenic Obesity: Epidemiologic Evidence, Pathophysiology, and Therapeutic Perspectives. Current Obesity Reports. https://doi.org/10.1007/s13679-019-00359-9
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.